Taiwan FDA registration d49161337dc7b6e908051037bf78ec35

Bondis Human Immunoglobulin A Reagent Kit

TW: 邦迪斯人類免疫球蛋白A試劑套組

Taiwan·Risk Class 2·THE BINDING SITE GROUP LIMITED·Registered Nov 05, 2012 – Nov 05, 2027Active

Registration details

Analysis ID: d49161337dc7b6e908051037bf78ec35
Customs Code: DHA00602410802

Company information

Manufacturer: THE BINDING SITE GROUP LIMITED
Manufacturer Country: United Kingdom
Authorized Representative: EVERLIGHT BIOTECH(TAIWAN) CO., LTD.

Product details

Intended Use: Quantitative detection of immunoglobulin A (IgA) in human serum, heparin lithium plasma, or EDTA plasma is required with a SPAPLUS analyzer.
Product Type (Level 1): C Immunology and microbiology
Product Type (Level 2): C.5510 免疫球蛋白A,G,M,D及E免疫試驗系統
Import Information: import

Dates and status

Registration Date: Nov 05, 2012
Expiry Date: Nov 05, 2027

About this record

Access comprehensive regulatory information for Bondis Human Immunoglobulin A Reagent Kit in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number d49161337dc7b6e908051037bf78ec35 and manufactured by THE BINDING SITE GROUP LIMITED. The authorized representative in Taiwan is EVERLIGHT BIOTECH(TAIWAN) CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.